Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Snow Lotus Stem Cell Small Molecule Peptides are a preparation of small molecule peptides derived from the stem cells of the snow lotus plant (*Saussurea involucrata*). This substance is being investigated in clinical trials for its potential effect on the nutritional status of cancer patients. Beyond its clinical investigation, it is widely marketed as a dietary supplement and nutraceutical, primarily for anti-aging, skin health, and overall vitality. Its proposed mechanisms of action include promoting cellular renewal, providing antioxidant protection, modulating immune responses, enhancing skin barrier function, inhibiting melanin production, and supporting cellular energy metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Snow Lotus Stem Cell Small Molecule Peptides.